Qiming-backed biopharma firm Gan & Lan seeks to raise $359m in Shanghai IPO

Qiming-backed biopharma firm Gan & Lan seeks to raise $359m in Shanghai IPO

19 June, 2020

Gan & Lee Pharmaceuticals Hillhouse Capital Qiming Venture Partners The Goldman Sachs Group

Printed by Unregistered user on Tue, 22 Jul 2025 15:07:00 GMT

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

You may also like

China's Stemirna to raise $50m for clinical trials of COVID vaccine pipeline

China IPO digest: DKEM raises $56m on ChiNext; Crastal Tech seeks $45m

Read more from Greater China

Venture Capital

Startup funding in Greater China grows 13% in Q2 on Ximalaya’s $2.4b deal

Cannot rely solely on valuation metrics for AI investments: Cathay Innovation